Gladstone NOW: The Campaign Join Us on the Journey ✕
91 - 105 of 122 Results Clear All
Jorge Palop has been appointed to assistant investigator at the Gladstone Institute of Neurological Disease.
Alzheimer’s Disease Palop Lab
Gladstone scientists have discovered how tau disrupts the ability of brain cells to form new memories in Alzheimer’s disease.
Alzheimer’s Disease Gan Lab
A cross-disciplinary collaboration seeks to connect the clinic and the laboratory and improve the translation of Alzheimer’s disease research.
Alzheimer’s Disease Finkbeiner Lab
New findings about Alzheimer’s disease advance the search for more effective treatments.
Alzheimer’s Disease Mucke Lab
Researchers from the Gladstone Institutes have shown for the first time that the protein BRCA1 is required for normal learning and memory and is depleted by Alzheimer’s disease.
Mucke Lab Alzheimer’s Disease
By repurposing a prescription drug used to treat rheumatoid arthritis, researchers at the Gladstone Institutes successfully reversed tau-related symptoms in an animal model of dementia.
Alzheimer’s Disease Gan Lab
Members of the Gladstone community raised funds and participated in the 2015 Annual Walk to End Alzheimer's.
Alzheimer’s Disease
Hear Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease, discuss progress towards Alzheimer’s cures during his recent City Arts & Lectures appearance.
Mucke Lab Alzheimer’s Disease
The initiative will fast-track new approaches to treat Alzheimer’s disease.
News Release Alzheimer’s Disease
Li Gan, PhD, has been selected to present the Inge Grundke-Iqbal Lecture for Alzheimer’s Research at the Alzheimer’s Association International Conference (AAIC) in Washington, D.C. in July.
Alzheimer’s Disease
Raising levels of the life-extending protein klotho can protect against learning and memory deficits in a mouse model of Alzheimer’s disease, despite the accumulation of Alzheimer-related toxins in the brain.
Mucke Lab Aging Alzheimer’s Disease
Low levels of the naturally occurring protein progranulin exacerbate cellular and cognitive dysfunction, while raising levels can prevent abnormalities in an Alzheimer model.
Alzheimer’s Disease
SAN FRANCISCO, CA—A new study from the Gladstone Institutes has revealed a way to alleviate the learning and memory deficits caused by apoE4, the most important genetic risk factor for Alzheimer’s disease, improving cognition to normal levels in aged mice.
Huang Lab Alzheimer’s Disease
A joint Gladstone-UCSF study reveals a gene linked to longevity also improves learning and memory. This discovery opens a new path for treating Alzheimer's and other aging-related diseases.
Research (Publication) Alzheimer’s Disease Mucke Lab Aging
SAN FRANCISCO, CA—Alzheimer’s disease is one of the greatest challenges facing modern medicine, but there is new hope in the fight against this deadly disease.
Huang Lab Mahley Lab Neurological Disease Alzheimer’s Disease
